News
BIOTRONIK introduces new unique Reliaty Pacing System Analyzer
BIOTRONIK SE & Co. KG, announced the European launch of the Reliaty pacing system analyzer after CE approval and successful pre-market evaluation. The pacing system analyzer (PSA) is used during an implantation of implantable pacemakers, implantable cardioverter-defibrillators (ICDs) and...
News
Tobotec Signs Multiple Agreements With Generic Manufacturers To Provide New HIV Treatment
Tibotec Pharmaceuticals today announced that it has granted multiple non-exclusive licenses to generic manufacturers including Hetero Drugs Limited, Matrix Laboratories Limited (a Mylan company) of India and Aspen Pharmacare of South Africa to manufacture, market and distribute the investigational...
News
Innovation drives Novartis to double-digit growth for 2010
Novartis achieved strong financial results in 2010 -Net sales up 14% (+14% in constant currencies, or cc) to USD 50.6 billion. Solid sales growth in fourth quarter, operating income impacted by one-offs and A(H1N1) pandemic flu vaccine sales in...
News
Aurobindo Pharma receives USFDA approval for Levofloxacin Tablets
Aurobindo Pharma Limited is pleased to announce that the company has received tentative approval from the US Food & Drug Administration to manufacture and market Levofloxacin tablets 250mg, 500mg and 750mg. Levofloxacin tablets 250mg, 500mg and...
News
Covidien Announces Launch of Puritan Bennett(TM) 520 Portable Ventilator
Covidien, a leading global provider of healthcare products and recognized innovator in mechanical ventilation and respiratory care devices, today announced that the Puritan Bennett(TM) 520 ventilator is now available in the European Union. The Puritan Bennett...
News
Mylan Receives Approval for Generic Version of Precose Tablets
Mylan Inc.announced that its subsidiary Mylan Pharmaceuticals Inc. has received final approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Acarbose Tablets, 25 mg, 50 mg and 100 mg, the generic...
News
Boehringer Ingelheim to Purchase Amgen’s Fremont Facility
Amgen Inc. and Boehringer Ingelheim announced they have signed an agreement under which Boehringer Ingelheim will acquire Amgen's rights in and substantially all assets at Amgen's Fremont California development and manufacturing facility. The transaction has been...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read